X4 Pharmaceuticals Inc (XFOR) — Net Asset Quality Index
X4 Pharmaceuticals Inc (XFOR) has a Net Asset Quality Index of 61.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $253.06 Million minus total liabilities of $97.61 Million yields net assets of $155.45 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check X4 Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
X4 Pharmaceuticals Inc Net Asset Quality Index Over Time (2015–2025)
This chart shows how X4 Pharmaceuticals Inc's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the index stands at 61.4%, representing net assets of $155.45 Million against total assets of $253.06 Million USD. See XFOR net asset value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for X4 Pharmaceuticals Inc (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for X4 Pharmaceuticals Inc from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of X4 Pharmaceuticals Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 64.1% | $186.29 Million | $290.46 Million | $104.17 Million | ▲ +49.0 pp |
| 2024 | 15.1% | $22.15 Million | $146.45 Million | $124.30 Million | ▼ -19.6 pp |
| 2023 | 34.7% | $51.10 Million | $147.26 Million | $96.16 Million | ▼ -12.9 pp |
| 2022 | 47.6% | $74.05 Million | $155.59 Million | $81.53 Million | ▼ -7.4 pp |
| 2021 | 55.0% | $64.41 Million | $117.18 Million | $52.76 Million | ▼ -4.3 pp |
| 2020 | 59.2% | $72.80 Million | $122.87 Million | $50.07 Million | ▼ -21.2 pp |
| 2019 | 80.4% | $129.22 Million | $160.70 Million | $31.48 Million | ▲ +20.4 pp |
| 2018 | 60.0% | $21.60 Million | $36.00 Million | $14.40 Million | ▼ -12.3 pp |
| 2017 | 72.3% | $58.71 Million | $81.25 Million | $22.55 Million | ▲ +292.2 pp |
| 2016 | -219.9% | $-16.72 Million | $7.60 Million | $24.33 Million | ▼ -173.9 pp |
| 2015 | -46.0% | $-4.37 Million | $9.51 Million | $13.88 Million | — |